XERIS PHARMACEUTICALS INC's ticker is XERS and the CUSIP is 98422L107. A total of 91 filers reported holding XERIS PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 0.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $1,139,000 | -37.9% | 465,049 | +3.2% | 0.02% | -35.3% |
| Q2 2021 | $1,833,000 | -6.3% | 450,414 | +3.9% | 0.03% | -17.1% |
| Q1 2021 | $1,956,000 | +27.2% | 433,710 | +38.7% | 0.04% | +17.1% |
| Q4 2020 | $1,538,000 | -25.1% | 312,590 | -9.8% | 0.04% | -50.0% |
| Q3 2020 | $2,054,000 | +127.0% | 346,428 | +1.8% | 0.07% | +112.1% |
| Q2 2020 | $905,000 | -35.5% | 340,403 | +312.6% | 0.03% | -66.7% |
| Q4 2018 | $1,403,000 | -39.2% | 82,504 | -37.1% | 0.10% | -20.8% |
| Q3 2018 | $2,306,000 | -7.1% | 131,145 | +0.3% | 0.12% | -16.1% |
| Q2 2018 | $2,481,000 | – | 130,700 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,498,666 | $42,477,000 | 1.70% |
| Redmile Group, LLC | 2,412,641 | $41,015,000 | 1.65% |
| SABBY MANAGEMENT, LLC | 202,916 | $3,450,000 | 0.76% |
| ArrowMark Colorado Holdings LLC | 652,748 | $11,097,000 | 0.12% |
| Granahan Investment Management | 82,504 | $1,403,000 | 0.10% |
| OppenheimerFunds, Inc. | 1,000,000 | $17,000,000 | 0.02% |
| FEDERATED HERMES, INC. | 300,000 | $5,100,000 | 0.01% |
| FMR LLC | 2,280,968 | $38,776,000 | 0.01% |
| Tower Research Capital LLC (TRC) | 1,016 | $17,000 | 0.00% |
| BlackRock Inc. | 645,035 | $10,966,000 | 0.00% |